Brady, Karen, Fitzgerald, Stephen, Ingvarsson, Sigurdur, Borrebaeck, Carl A.K. and Moynagh, Paul N. (2001) CD40 Employs p38 MAP Kinase in IgE Isotype Switching. Biochemical and Biophysical Research Communications, 289 (1). pp. 276-281. ISSN 0006-291X
Preview
PM_CD40 2001.pdf
Download (256kB) | Preview
Abstract
IgE switching requires the prior induction of Ce
germline transcripts which is mediated by the concerted
binding of STAT-6 and NFkB to the Ce promoter.
These transcription factors are regulated by
IL-4 and CD40, respectively. However the latter can
effect other signaling pathways and the present study
explores the role of p38 MAPK in induction of Ce germline
transcripts. CD40 and IL-4, both alone and in synergy,
were initially shown to activate the Ce promoter
in a B cell lymphoma cell line. Under the same conditions
CD40 caused activation of p38 MAPK, whereas
IL-4 was ineffective. The p38 MAPK inhibitor,
SB203580, and a dominant negative form of p38 MAPK
decreased the CD40 activation of the Ce promoter by
reducing the ability of CD40 to increase the transactivation
potential of NFkB. This study suggests that p38
MAPK is crucially important in mediating CD40 activation
of NFkB which acts to induce Ce germline transcripts,
ultimately facilitating IgE switching.
Item Type: | Article |
---|---|
Additional Information: | The work was supported by the European Commission 4th Framework Biotechnology Programme (BIO4 CT96 0246), 5th Framework Biotechnology Programme (QLK3-CT-2000-00270), and Enterprise Ireland. |
Keywords: | CD40; IgE; isotype switching; allergy; p38 MAP kinase; NFkB; |
Academic Unit: | Faculty of Science and Engineering > Biology |
Item ID: | 7187 |
Identification Number: | 10.1006/bbrc.2001.5968 |
Depositing User: | Professor Paul Moynagh |
Date Deposited: | 15 Jul 2016 11:06 |
Journal or Publication Title: | Biochemical and Biophysical Research Communications |
Publisher: | Academic Press |
Refereed: | Yes |
Funders: | European Commission 4th Framework Biotechnology Programme, European Commission 5th Framework Biotechnology Programme, Enterprise Ireland (EI) |
Related URLs: | |
URI: | https://mural.maynoothuniversity.ie/id/eprint/7187 |
Use Licence: | This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here |
Repository Staff Only (login required)
Downloads
Downloads per month over past year